Deng Xin-Sheng, Meng Xianzhong, Zeng QingChun, Fullerton David, Mitchell Max, Jaggers James
Cardiothoracic Surgery, University of Colorado, Children's Hospital Colorado, Aurora, Colorado; Cardiothoracic Surgery, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
Cardiothoracic Surgery, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
Ann Thorac Surg. 2015 Jan;99(1):62-71. doi: 10.1016/j.athoracsur.2014.07.027. Epub 2014 Oct 22.
Aortic valve interstitial cells (AVICs) have been implicated in the pathogenesis of calcific aortic valve disease. Signal transducer and activator of transcription 3 (Stat3) possesses antiinflammatory effects. Given that calcification occurs in adult valves, we hypothesized that AVICs from adult valves more likely undergo a proosteogenic phenotypic change than those from pediatric valves and that may be related to different Stat3 activation in the response of those two age groups to toll-like receptor 4 (TLR4).
AVICs from healthy human aortic valve tissues were treated with TLR4 agonist lipopolysaccharide. Cellular levels of TLR4, intercellular adhesion molecule 1, bone morphogenetic protein 2, and alkaline phosphatase, as well as phosphorylation of p-38 mitogen-activated protein kinase (MAPK), nuclear factor-κβ (NF-κβ), and Stat3, were analyzed.
Toll-like receptor 4 protein levels were comparable between adult and pediatric AVICs. Adult cells produce markedly higher levels of the above markers after TLR4 stimulation, which is negatively associated with phosphorylation of Stat3. Inhibition of Stat3 enhanced p-38 MAPK and NF-κβ phosphorylation and exaggerated the expression of the above markers in pediatric AVICs after TLR4 stimulation.
Adult AVICs exhibit greater inflammatory and osteogenic responses to TLR4 stimulation. The enhanced responses in adult AVICs are at least partly due to lower levels of Stat3 activation in response to TLR4 stimulation relative to pediatric cells. Stat3 functions as a negative regulator of the TLR4 responses in human AVICs. The results suggest that Stat3 activation (tyrosine phosphorylation) may be protective and that TLR4 inhibition could be targeted pharmacologically to treat calcific aortic valve disease.
主动脉瓣间质细胞(AVICs)与钙化性主动脉瓣疾病的发病机制有关。信号转导和转录激活因子3(Stat3)具有抗炎作用。鉴于钙化发生在成人瓣膜中,我们推测来自成人瓣膜的AVICs比来自儿童瓣膜的AVICs更易发生促骨生成的表型改变,这可能与这两个年龄组对Toll样受体4(TLR4)反应中不同的Stat3激活有关。
用TLR4激动剂脂多糖处理来自健康人主动脉瓣组织的AVICs。分析TLR4、细胞间黏附分子1、骨形态发生蛋白2和碱性磷酸酶的细胞水平,以及p-38丝裂原活化蛋白激酶(MAPK)、核因子-κβ(NF-κβ)和Stat3的磷酸化水平。
成人和儿童AVICs之间的Toll样受体4蛋白水平相当。成人细胞在TLR4刺激后产生的上述标志物水平明显更高,这与Stat3的磷酸化呈负相关。抑制Stat3可增强p-38 MAPK和NF-κβ的磷酸化,并在TLR4刺激后使儿童AVICs中上述标志物的表达增加。
成人AVICs对TLR4刺激表现出更大的炎症和成骨反应。成人AVICs中增强的反应至少部分是由于相对于儿童细胞,对TLR4刺激的Stat3激活水平较低。Stat3在人AVICs中作为TLR4反应的负调节因子发挥作用。结果表明Stat3激活(酪氨酸磷酸化)可能具有保护作用,并且TLR4抑制可作为药物治疗靶点用于治疗钙化性主动脉瓣疾病。